Friess Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-58,235
| Closed | -$8.17M | – | 132 |
|
|
2017
Q3 | $8.17M | Buy |
58,235
+1,335
| +2% | +$187K | 0.72% | 65 |
|
|
2017
Q2 | $6.92M | Buy |
+56,900
| New | +$6.92M | 0.63% | 69 |
|
|
2015
Q2 | – | Sell |
-99,100
| Closed | -$17.2M | – | 174 |
|
|
2015
Q1 | $17.2M | Buy |
99,100
+69,100
| +230% | +$12M | 1.39% | 31 |
|
|
2014
Q4 | $5.55M | Buy |
+30,000
| New | +$5.55M | 0.45% | 73 |
|